Trials In Focus: FDA Guidance Aims To Tackle Challenges In Multi-Endpoint Trials

Guidance Targets ‘Multiplicity Problem’

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.